Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Omicron and Delta Variant of SARS-CoV-2: A Comparative Computational Study of Spike protein
Suresh Kumar, Thiviya S. Thambiraja, Kalimuthu Karuppanan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines
Yusha Araf, F. Akter, Yan‐Dong Tang, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 1825-1832
Open Access | Times Cited: 781
SARS‐CoV‐2 Omicron variant: Characteristics and prevention
Xuemei He, Weiqi Hong, Xiangyu Pan, et al.
MedComm (2021) Vol. 2, Iss. 4, pp. 838-845
Open Access | Times Cited: 494
Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron
Zhen Cui, Pan Liu, Nan Wang, et al.
Cell (2022) Vol. 185, Iss. 5, pp. 860-871.e13
Open Access | Times Cited: 379
Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic
Rekha Khandia, Shailja Singhal, Taha Alqahtani, et al.
Environmental Research (2022) Vol. 209, pp. 112816-112816
Open Access | Times Cited: 273
A review on evolution of emerging SARS-CoV-2 variants based on spike glycoprotein
Nimisha Ghosh, Suman Nandi, Indrajit Saha
International Immunopharmacology (2022) Vol. 105, pp. 108565-108565
Open Access | Times Cited: 61
Omicron Genetic and Clinical Peculiarities That May Overturn SARS-CoV-2 Pandemic: A Literature Review
Giorgio Tiecco, Samuele Storti, Melania Degli Antoni, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 1987-1987
Open Access | Times Cited: 54
Literature Review of Omicron: A Grim Reality Amidst COVID-19
Suraj Arora, Vishakha Grover, Priyanka Saluja, et al.
Microorganisms (2022) Vol. 10, Iss. 2, pp. 451-451
Open Access | Times Cited: 49
Omicron (BA.1) and Sub-Variants (BA.1, BA.2 and BA.3) of SARS-CoV-2 Spike Infectivity and Pathogenicity: A Comparative Sequence and Structural-based Computational Assessment
Suresh Kumar, Kalimuthu Karuppanan, Gunasekaran Subramaniam
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Closed Access | Times Cited: 46
Challenges of Muhammadiyah’s Contribution in Handling Covid-19 in The MCCC Program in Indonesia
Nurul Humaidi, Rani Darmayanti, Rahmad Sugianto
Khazanah Sosial (2022) Vol. 4, Iss. 1, pp. 176-186
Open Access | Times Cited: 38
Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England
Hester Allen, Elise Tessier, Charlie Turner, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 34
A comprehensive review on Covid-19 Omicron (B.1.1.529) variant
R. Manjunath, Santosh L. Gaonkar, Ebraheem Abdu Musad Saleh, et al.
Saudi Journal of Biological Sciences (2022) Vol. 29, Iss. 9, pp. 103372-103372
Open Access | Times Cited: 31
Humoral and Cellular Immune Responses of COVID-19 vaccines against SARS-Cov-2 Omicron variant: a systemic review
Zhonghao Chen, Ying Zhang, Meng Wang, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 12, pp. 4629-4641
Open Access | Times Cited: 30
Evolution and Clinical Trend of SARS-CoV-2 Variants
Miguel Lorente-González, Miguel Suarez-Ortiz, Pedro Landete
Open Respiratory Archives (2022) Vol. 4, Iss. 2, pp. 100169-100169
Open Access | Times Cited: 24
Development and application of ribonucleic acid therapy strategies against COVID-19
Lin Ning, Mujiexin Liu, Yushu Gou, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 13, pp. 5070-5085
Open Access | Times Cited: 21
Omicron variant infection and the associated immunological scenario
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Reshma Murali, et al.
Immunobiology (2022) Vol. 227, Iss. 3, pp. 152222-152222
Open Access | Times Cited: 19
Analysis of a SARS-CoV-2 convalescent cohort identified a common strategy for escape of vaccine-induced anti-RBD antibodies by Beta and Omicron variants
Matthew Chang, Hanzhong Ke, Christian D. Coherd, et al.
EBioMedicine (2022) Vol. 80, pp. 104025-104025
Open Access | Times Cited: 17
In silico discovery of 3 novel quercetin derivatives against papain-like protease, spike protein, and 3C-like protease of SARS-CoV-2
Kunal Bhattacharya, Ripunjoy Bordoloi, Nongmaithem Randhoni Chanu, et al.
Journal of Genetic Engineering and Biotechnology (2022) Vol. 20, Iss. 1, pp. 43-43
Open Access | Times Cited: 16
SARS-CoV-2 and the central nervous system: Emerging insights into hemorrhage-associated neurological consequences and therapeutic considerations
Joy Mitra, Manohar Kodavati, Vincent E. Provasek, et al.
Ageing Research Reviews (2022) Vol. 80, pp. 101687-101687
Open Access | Times Cited: 16
A study on the effect of natural products against the transmission of B.1.1.529 Omicron
Samar Sami Alkafaas, Abanoub Mosaad Abdallah, Aya Misbah Hussien, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 9
Human serum from SARS-CoV-2 vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant
Maren Schubert, Federico Bertoglio, Stephan Steinke, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 22
Emergency Protective Measures and Strategies of COVID-19: From Lifestyle to Traditional Chinese Medicine
Chunsong Hu
Clinical Complementary Medicine and Pharmacology (2023) Vol. 3, Iss. 3, pp. 100089-100089
Open Access | Times Cited: 8
Steep Decline in Binding Capability of SARS-CoV-2 Omicron Variant (B.1.1.529) RBD to the Antibodies in Early COVID-19 Convalescent Sera and Inactivated Vaccine Sera
Wenhao Zhou, Ping He, Junhua Li, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 335-335
Open Access | Times Cited: 13
Intensity and Dynamics of Anti-SARS-CoV-2 Immune Responses after BNT162b2 mRNA Vaccination: Implications for Public Health Vaccination Strategies
Matthaios Speletas, Ioanna Voulgaridi, Styliani Sarrou, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 316-316
Open Access | Times Cited: 13
SARS-CoV-2 omicron spike simulations: broad antibody escape, weakened ACE2 binding, and modest furin cleavage
M. Zaki Jawaid, A. Baidya, R. Mahboubi-Ardakani, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 7
Omicron: The rising fear for another wave in Malaysia
Lydia Ngiik-Shiew Law, Ke-Yan Loo, Joanna Xuan Hui Goh, et al.
Progress In Microbes & Molecular Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top